ES2078978T3 - Procedimiento de determinacion cromogenica de niveles de factores de coagulacion sanguinea en plasma y otros fluidos. - Google Patents

Procedimiento de determinacion cromogenica de niveles de factores de coagulacion sanguinea en plasma y otros fluidos.

Info

Publication number
ES2078978T3
ES2078978T3 ES90913146T ES90913146T ES2078978T3 ES 2078978 T3 ES2078978 T3 ES 2078978T3 ES 90913146 T ES90913146 T ES 90913146T ES 90913146 T ES90913146 T ES 90913146T ES 2078978 T3 ES2078978 T3 ES 2078978T3
Authority
ES
Spain
Prior art keywords
factor
blood coagulation
fluids
plasma
levels
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90913146T
Other languages
English (en)
Inventor
Hendrik Coenraad Hemker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare Corp
Original Assignee
Baxter Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Diagnostics Inc filed Critical Baxter Diagnostics Inc
Application granted granted Critical
Publication of ES2078978T3 publication Critical patent/ES2078978T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
    • C12Q2337/10—Anilides
    • C12Q2337/12—Para-Nitroanilides p-NA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444—Factor X (3.4.21.6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/9645—Factor IX (3.4.21.22)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96452—Factor XI (3.4.21.27)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/966—Chemistry: molecular biology and microbiology involving an enzyme system with high turnover rate or complement magnified assay, e.g. multi-enzyme systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

ES UN ENSAYO CROMOGENICO PARA LA DETERMINACION DEL FACTOR IX DE LA COAGULACION DE LA SANGRE (FACTOR CHRISTMAS) QUE UTILIZA EL FACTOR XA FORMADO POR LA CONVERSION DEL FACTOR X POR LA ACTIVACION DEL FACTOR IX PARA DIVIDIR UN SUSTRATO CROMOGENICO. LA CONVERSION DEL FACTOR X EN FACTOR XA SE EMPAREJA A UNA CONVERSION MEDIADA DEL FACTOR XI AL FACTOR IXA EN UN PROCESO SUSTANCIAL DE DOS FASES.
ES90913146T 1989-08-17 1990-08-16 Procedimiento de determinacion cromogenica de niveles de factores de coagulacion sanguinea en plasma y otros fluidos. Expired - Lifetime ES2078978T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39482289A 1989-08-17 1989-08-17

Publications (1)

Publication Number Publication Date
ES2078978T3 true ES2078978T3 (es) 1996-01-01

Family

ID=23560559

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90913146T Expired - Lifetime ES2078978T3 (es) 1989-08-17 1990-08-16 Procedimiento de determinacion cromogenica de niveles de factores de coagulacion sanguinea en plasma y otros fluidos.

Country Status (7)

Country Link
US (1) US5627038A (es)
EP (1) EP0440775B1 (es)
JP (1) JP3041457B2 (es)
CA (1) CA2039173C (es)
DE (1) DE69022019T2 (es)
ES (1) ES2078978T3 (es)
WO (1) WO1991002813A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992018539A1 (en) * 1991-04-15 1992-10-29 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce METHOD FOR EVALUATING CONTRIBUTIONS OF EXTRINSIC AND INTRINSIC COAGULATION FACTORS TO A FACTOR Xa ASSAY
JPH08327631A (ja) * 1995-06-01 1996-12-13 Eisai Co Ltd 血液凝固活性測定試薬
EP2177624A1 (en) * 2008-10-02 2010-04-21 Siemens Healthcare Diagnostics Products GmbH Blood coagulation assays
EP2471945A1 (de) * 2010-12-30 2012-07-04 Siemens Healthcare Diagnostics Products GmbH Verfahren zur Bestimmung von Inhibitoren der Gerinnung
CA2864868A1 (en) 2011-02-25 2012-11-15 Wellstat Diagnostics, Llc Assays for detecting enzymatic activity
WO2014018777A2 (en) * 2012-07-25 2014-01-30 Biogen Idec Ma Inc. Blood factor monitoring assay and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1161432A (en) * 1980-02-12 1984-01-31 Lars G. Svendsen Tripeptide derivatives and their application in assaying enzymes
JPS60241900A (ja) * 1984-05-16 1985-11-30 Nitto Boseki Co Ltd 新規な第Ｘａ因子活性測定用基質
DE3516579A1 (de) * 1984-11-19 1986-05-22 Boehringer Mannheim Gmbh, 6800 Mannheim Gerinnungstest auf teststreifen
DE3788944T2 (de) * 1986-06-24 1994-05-26 Novonordisk As Verfahren zur herstellung eines koagulationsaktiven komplexes vom faktor viii-fragment.

Also Published As

Publication number Publication date
CA2039173A1 (en) 1991-02-18
JPH04501809A (ja) 1992-04-02
DE69022019D1 (de) 1995-10-05
EP0440775B1 (en) 1995-08-30
CA2039173C (en) 1997-04-01
DE69022019T2 (de) 1996-05-02
JP3041457B2 (ja) 2000-05-15
US5627038A (en) 1997-05-06
WO1991002813A1 (en) 1991-03-07
EP0440775A1 (en) 1991-08-14

Similar Documents

Publication Publication Date Title
Macfarlane An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier
Harlan et al. Role of hydrogen peroxide in the neutrophil-mediated release of prostacyclin from cultured endothelial cells.
Shen et al. Thrombosis and a hypercoagulable state in HIV-infected patients
ES2072970T3 (es) Metodo para determinar el potencial de trombina endogeno del plasma y de la sangre, y tambien un equipo para su uso en dicho metodo.
ATE116857T1 (de) Oligodesoxynukleotide als inhibitoren der replikation von retroviren und der expression von onkogenen.
ES2033774T5 (es) Derivados antiviricos fosfonometoxialquilenicos de purina y pirimidina.
DK1169298T3 (da) Farmaceutiske forbindelser
MX9303746A (es) Articulos adhesivos posicionables y reposicionables y metodo para su fabricacion.
IT1070002B (it) Substrato cromogeno o fluorescente impiegabile come reagente per la determinazione quantitativa di enzimi proteolitici del gruppo e.c. 3.4.4.
ES2078978T3 (es) Procedimiento de determinacion cromogenica de niveles de factores de coagulacion sanguinea en plasma y otros fluidos.
ES2042547T3 (es) Un procedimiento para preparar una formulacion de tableta a capsula de liberacion sostenida.
SE7902555L (sv) Forfarande och reagens for bestemning av biologiskt aktivt heparin i plasma
ES2063365T3 (es) Composiciones anticoagulantes basadas en el factor xa.
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
ES2062292T3 (es) Un proceso para la preparacion del compuesto que tiene la estructura (7alfa,17alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-in-3-ona.
ES2055291T5 (es) Material de gel acrilico y preparacion de gel acrilico.
ES2075027T3 (es) Tratamiento de superficie para mejorar la adhesion de pinturas a poli(diciclopentadieno).
DK163893C (da) Varmepumpe
ATE43641T1 (de) Bestimmung von prokallikrein.
Verstraete et al. An overview of antiplatelet and antithrombotic drugs
ATE354640T1 (de) Herstellung von geschichteten und nach zelltyp geordneten geweben in vitro
ES2061942T3 (es) Composicion farmaceutica util para el tratamiento de enfermedades cardiovasculares.
EP0332952A3 (de) Kombination von polysulfatierten Heparinen bei der Bekämpfung von Retrovirusinfektionen
PE74799A1 (es) Combinaciones antivirales
ES2077232T3 (es) Procedimiento de determinacion de niveles del factor viii:ca de coagulacion sanguinea en distintas muestras.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 440775

Country of ref document: ES